$HGEN News Article - Humanigen Announces Publication of Results From Phase 3 Randomized Double-Blind Placebo-Controlled Study Demonstrating the Efficacy and Safety of Lenzilumab(TM) in Hospitalized COVID-19 Patients
https://marketwirenews.com/news-releases/huma...85163.html